Skypeptides represent a truly fresh class of therapeutics, designed by strategically integrating short peptide sequences with specific structural motifs. These brilliant constructs, often mimicking the secondary structures of larger proteins, are revealing immense potential for targeting a broad spectrum of diseases. Unlike traditional peptide ther

VIP peptide has emerged as a compelling therapeutic target for a variety of diseases. This neuropeptide exhibits potent effects on the central nervous system, influencing processes such as pain perception, inflammation, and gut function. Research suggests that VIP peptide may hold promise in treating conditions like autoimmune disorders, degenerati